Publicaciones en las que colabora con ENRIQUE ECHEVARRIA ORELLA (30)

2023

  1. Efecto de la pandemia en la prescripción de tratamientos para las adicciones

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

2019

  1. Factores influyentes en la calidad de la prescripción en atención primaria y relación con el gasto farmacéutico

    Revista espanola de salud publica, Vol. 93

2018

  1. A randomised controlled trial of a program based on the theory of planned behavior to promote fruit and vegetable intake among schoolchildren: PROFRUVE study protocol

    BMC Public Health, Vol. 18, Núm. 1

  2. Análisis de la utilización de antiulcerosos inhibidores de la bomba de protones en el área de atención primaria de la comarca Araba

    Revista espanola de salud publica, Vol. 92

  3. The surge in biosimilars: considerations for effective pharmacovigilance and EU regulation

    Therapeutic Advances in Drug Safety, Vol. 9, Núm. 10, pp. 601-608

2015

  1. Plasma peptidases as prognostic biomarkers in patients with first-episode psychosis

    Psychiatry Research, Vol. 228, Núm. 2, pp. 197-202

2012

  1. Adaptive response in the antioxidant defence system in the course and outcome in first-episode schizophrenia patients: A 12-months follow-up study

    Psychiatry Research, Vol. 200, Núm. 2-3, pp. 218-222

  2. Cognitive impairment is related to oxidative stress and chemokine levels in first psychotic episodes

    Schizophrenia Research, Vol. 137, Núm. 1-3, pp. 66-72

  3. Dextran-protamine-solid lipid nanoparticles as a non-viral vector for gene therapy: In vitro characterization and in vivo transfection after intravenous administration to mice

    International Journal of Pharmaceutics, Vol. 425, Núm. 1-2, pp. 35-43

2010

  1. Sauna, nerbio-anorexiaren irtenbide ote?

    Elhuyar: zientzia eta teknika, Núm. 267, pp. 50-53

  2. Solid lipid nanoparticles as potential tools for gene therapy: In vivo protein expression after intravenous administration

    International Journal of Pharmaceutics, Vol. 385, Núm. 1-2, pp. 157-162

2009

  1. A study of the toxic effect of oxidized sunflower oil containing 4-hydroperoxy-2-nonenal and 4-hydroxy-2-nonenal on cortical TrkA receptor expression in rats

    Nutritional Neuroscience, Vol. 12, Núm. 6, pp. 249-259

  2. High ambient temperature reverses hypothalamic MC4 receptor overexpression in an animal model of anorexia nervosa

    Psychoneuroendocrinology, Vol. 34, Núm. 3, pp. 420-429

2008

  1. Brain endocannabinoid system is invoived in fluoxetine-induced anorexia

    Nutritional Neuroscience, Vol. 11, Núm. 3, pp. 111-118

  2. Distribution and neurochemical characterization of neurons expressing GIRK channels in the rat brain

    Journal of Comparative Neurology, Vol. 510, Núm. 6, pp. 581-606

  3. Effects of fluoxetine administration on hypothalamic melanocortin system in obese Zucker rats

    Neuropeptides, Vol. 42, Núm. 3, pp. 293-299

  4. Immunohistochemical localization of CB1 cannabinoid receptors in frontal cortex and related limbic areas in obese Zucker rats: Effects of chronic fluoxetine treatment

    Brain Research, Vol. 1236, pp. 57-72

  5. Janari lasterra neuronen etsai

    Ekaia: Euskal Herriko Unibertsitateko zientzi eta teknologi aldizkaria, Núm. 21, pp. 131-139

  6. Kalitatezko unibertsitatea lortzeko taldeko lan kooperatiboan oinarrituriko irakasketa-ikasketa metodo baten azterketa

    La innovación educativa en la universidad: adaptación al cambio (Servicio de Publicaciones), pp. 57-68

2006

  1. Fluoxetine alters mu opioid receptor expression in obese Zucker rat extrahypothalamic regions

    International Journal of Neuroscience, Vol. 116, Núm. 3, pp. 289-298